Thalassemia in the Philippines

Hemoglobin. 2022 Jan;46(1):36-38. doi: 10.1080/03630269.2021.2023566.

Abstract

For an archipelago that has a rich history of trade with overseas merchants and colonial rule, the Philippine Islands are models of ethnic and cultural diversity, including hereditary blood disorders such as hemoglobinopathies. Pending a government-led comprehensive national screening program, available cluster data provides evidence of the prevalence of thalassemia in the country. The National Blood Services Act of 1994 was enacted to promote voluntary blood donation to address the supply of blood products but falls short in addressing the immense blood transfusion requirements of the thalassemic community. Iron overload monitoring and management is a considerable challenge due to high cost of laboratory tests and iron chelators on top of minimal health insurance coverage for the majority of Filipino patients with thalassemia. Continuous engagement with the thalassemia patient community and multi sectoral efforts are the means to ensure sustained improvement in the delivery of care.

Keywords: Balikatang Thalassemia (Ba-Tha); Philippine patient community; thalassemia care; thalassemia screening.

Publication types

  • Review

MeSH terms

  • Hemoglobinopathies*
  • Humans
  • Iron Chelating Agents / therapeutic use
  • Iron Overload* / diagnosis
  • Iron Overload* / epidemiology
  • Iron Overload* / etiology
  • Philippines / epidemiology
  • Thalassemia* / diagnosis
  • Thalassemia* / epidemiology
  • Thalassemia* / therapy

Substances

  • Iron Chelating Agents